Consensus of the Chinese Specialists for Diagnosis, treatment & control of acinetobacter baumannii infection

National Medical Journal of China

Volumn 92, Issue 2, 2012, Pages 76-85

  Chen, Bai Yi ^a   He, Li Xian ^a   Hu, Bi Jie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER BAUMANNII; ARTICLE; NONHUMAN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; HUMANS;

EID: 84862735911     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.02.002     Document Type: Article

References (57)

1. Peleg A Y, Seifert H, Paterson D L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev, 2008, 21: 538-582.
2. Falagas M E, Koletsi P K, Bliziotis I A. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol, 2006, 55: 1619-1629.
3. Paterson D L, Doi Y. A step closer to extreme drug resistance (XDR) in gram-negative bacilli. Clin Infect Dis, 2007, 45: 1179-1181.
4. Falagas M E, Karageorgopoulos D E. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis, 2008, 46: 1121-1122; author reply 1122.
5. Zhou H, Yang Q, Yu Y S, et al. Clonal Spread of Imipenemresistant Acinetobacter baumannii among different cities of China. J Clin Microbiol, 2007, 45: 4054-4057.
6. Perez F, Hujer A M, Hujer K M, et al. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother, 2007, 51: 3471-3484.
7. Munoz-Price L S, Robert A W. Acinetobacter Infection. N Engl J Med, 2008, 358: 1271-1281.
8. Guardado A R, Blanco A, Asensi V, et al. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters; assessment of different treatments. J Antimicrob Chemother, 2008, 61: 908-913.
9. Lenie D, Alexandr N, Harald S. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol, 2007, 5: 939-951.
10. 2009, 3: 427-432.
11. Falagas M E, Karveli E A, Kelesidis I, et al. Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis, 2007, 26: 857-868.
12. Galani I, Flora K, Maria S, et al. Colistin susceptibility testing by Etest and disk diffusion methods. Int J Antimicrob Agents, 2008, 31, 434-439.
13. Zhou H, Zhang T, Yu D, et al. Genomic analysis of the multidrug resistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China. Antimicrob Agents Chemother, 2011, 55: 4506-4512.
14. Bergogne E, Towner K J. Acinetobacter spp. as Nosocomial Pathogens; Microbiological, Clinical, and Epidemiological Features. Clin Microbiol Rev, 1996, 9: 148-165.
15. La Scola B, Gundi V A, Khamis A, et al. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol, 2006, 44: 827-832.
16. Turton J F, Woodford N, Glover J, et al. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol, 2006, 44: 2974-2976.
17. Ecker J A, Massire C, Hall T A, et al. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J Clin Microbiol, 2006, 44: 2921-2932.
18. Higgins P C, Wisplinghoff H, Krut O, et al. A PCR based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin Microbiol Infect, 2007, 13: 1199-1201.
19. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement. Wayne, Pa. Clinical and Laboratory Standards Institute, 2011: M100-S21.
20. Fishbain J, Peleg A Y. Treatment of Acinetobacter infections. Clin Infect Dis, 2010, 51: 79-84.
21. Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis, 2010, 23: 332-339.
22. Neonakis I K, Spandidos D A, Petinaki E. Confronting multidrug-resistant Acinetobacter baumannii: a review. Int J Antimicrob Agents, 2011, 37: 102-109.
23. Jian Li, Craig R R, Roger L N, et al. Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii. Antimicrob Agents Chemother, 2006, 50: 2946-2950.
24. Waites K B, Duffy L B, Dowzicky M J. Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial. Antimicrob Agents Chemother, 2006, 50: 3479-3484.
25. Navon-Venezia S, Leavitt A, Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother, 2007, 59: 772-774.
26. Lee N Y, Wang C L, Chuang Y C, et al. Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study. Pharmacotherapy, 2007, 27: 1506-1511.
27. Kiffer C R, Sampaio J L, Sinto S, et al. In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii. Diagn Microbiol Infect Dis, 2005, 52: 317-322.
28. Petrosillo N, Ioannidou E, Falagas M E. Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clin Microbiol Infect, 2008, 14: 816-827.
29. Sopirala M M, Mangino J E, Gebreyes W A, et al. Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother, 2010, 54: 4678-4683.
30. Entenza J M, Moreillon P. Tigecycline in combination with other antimicrobials; a review of in vitro, animal and case report studies. Int J Antimicrob Agents, 2009, 34: 8.e1-9.
31. Petersen P J, Labthavikul P, Jones C H, et al. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother, 2006, 57: 573-576.
32. Jennifer H M, Marina H, Paul H. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother, 2010, 54: 4971-4977.
33. Luna C M, Aruj P K. Nosocomial Acinetobacter pneumonia. Respirology, 2007, 12: 787-791.
34. Towner K J. Acinetobacter: an old friend, but a new enemy. J Hosp Infect, 2009, 73: 355-363.
35. Hilmar W, Michael B, Edmond M A, et al. Nosocomial bloodstream infections caused by Acinetobacter species in united states hospitals; clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis, 2000, 31: 690-697.
36. Trottier V, Namias N, Pust D G, et al. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients. Surg Infect (Larchmt), 2007, 8: 437-143.
37. Rodriguez-Bano J, Cisneros J M, Fernandez-Cuenca F, et al. Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control Hosp Epidemiol, 2004, 25: 819-824.
38. 2011: 230-256.
39. Mermel L A, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis, 2009, 49: 1-45.
40. 2008, 28: 413-421.
41. Lemuel L Dent, Dana R M, Siddharth P, et al. Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infectious Diseases, 2010, 10: 196.
42. Solomkin J S, Mazuski J E, Bradley J S, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children; guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis, 2010, 50: 133-164.
43. Akkoyun S, Kuloglu F, Tokuc B. Etiologic agents and risk factors in nosocomial urinary tract infections. Mikrobiyol Bui, 2008, 42: 245-254.
44. Hooton T M, Bradley S F, Cardenas D D, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults; 2009 international clinical practice guidelines from the infectious diseases society of America. Clin Infect Dis, 2010, 50: 625-663.
45. Tenke P, Kovacs B, Bjerklund Johansen T E, et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents, 2008, 31: S68-S78.
46. Petersen K, Riddle M S, Danko J R, et al. Trauma-related infections in battlefield casualties from Iraq. Ann Surg, 2007, 245: 803-811.
47. Murray C K. Acinetobacter skin carriage among US army soldiers deployed in Iraq. Infect Control Hosp Epidemiol, 2007, 28: 720-722.
48. 2009, 38: 810-812.
49. Corradino B, Toia F, Di Lorenzo S, et al. A difficult case of necrotizing fasciitis caused by Acinetobacter baumannii. Int J Low Extrem Wounds, 2010, 9: 152-154.
50. Duan X, Yang L, Xia P. Septic arthritis of the knee caused by antibiotic-resistant Acinetobacter baumannii in a gout patient; a rare case report. Arch Orthop Trauma Surg, 2010, 130: 381-384.
51. Lachanas E, Tomos P, Sfyras N, et al. Acinetobacter baumannii mediastinitis after cardiopulmonary bypass: case report and literature review. Surg Infect (Larchmt), 2008, 9: 201-204.
52. Tekce Ay, Erbay A, Cabadak H, et al. Pan-resistant Acinetobacter baumannii mediastinitis treated successfully with tigecycline: a case report. Surg Infect (Larchmt), 2011, 12: 141-143.
53. Schafer J, Mangino Je. Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq. Emerg Infect Dis, 2008, 14: 512-514.
54. Marioni G, Marchese-Ragona R, Boldrin C, et al. Deep neck abscess due to Acinetobacter baumannii infection. Am J Otolaryngol, 2010, 31: 304-307.
55. Aivazova V, Kainer F, Friese K, et al. Acinetobacter baumannii infection during pregnancy and puerperium. Arch Gynecol Obstet, 2010, 281: 171-174.
56. Boyce J M, Pittet D. Guideline for Hand Hygiene in Health Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recommendations and reports; Morbidity and mortality weekly report Recommendations and reports/Centers for Disease Control, 2002, 52: 1-45.
57. Pittet D, Allegranzi B, Boyce J, et al. The World Health Organization Guidelines on Hand Hygiene in Health Care and their consensus recommendations. Infect Control Hospital Epidemiol, 2009, 30: 611-622.